Oral vaccination against Helicobacter pylori with recombinant cholera toxin B-subunit

Helicobacter

Volumn 10, Issue 4, 2005, Pages 345-352

  Kubota, Eiji ^a   Joh, Takashi ^a   Tanida, Satoshi ^a   Sasaki, Makoto ^a   Kataoka, Hiromi ^a   Watanabe, Katsushi ^a   Itoh, Keisuke ^a   Oshima, Tadayuki ^a   Ogasawara, Naotaka ^a   Togawa, Shouzo ^a   Wada, Tsuneya ^a   Yamada, Tomonori ^a   Mori, Yoshinori ^a   Fujita, Fumitaka ^a   Shimura, Takaya ^a   Ohara, Hirotaka ^a   Isaka, Masanori ^a   Yasudat, Yoko ^a   Itoh, Makoto ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Helicobacter pylori; Oral vaccination; rCTB

Indexed keywords

BACTERIAL ANTIGEN; CHOLERA TOXIN B SUBUNIT; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GASTRITIS; GROWTH INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; STOMACH MUCOSA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA TOXIN; COLONY COUNT, MICROBIAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

HELICOBACTER PYLORI;

EID: 23344452283     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00328.x     Document Type: Article

References (22)

1. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995;55:562-5.
2. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-2694.
3. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
4. Michetti P. Vaccine against Helicobacter pylori: Fact or fiction? Gut 1997;41:728-30.
5. Murakami K, Sato R, Okimoto T, et al. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol Ther 2002;16:1933-8.
6. Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 2001;69:158-68.
7. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
8. Jakobsen H, Schulz D, Pizza M, Rappuoli R, Jonsdottir I. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections. Infect Immun 1999;67:5892-7.
9. Isaka M, Yasuda Y, Kozuka S, Taniguchi T, Miura Y, Matano K, Goto N, Tochikubo K. Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid. Vaccine 1999;17:944-8.
10. Isaka M, Yasuda Y, Kozuka S, Miura Y, Taniguchi T, Matano K, Goto N, Tochikubo K. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit. Vaccine 1998;16:1620-6.
11. Tochikubo K, Isaka M, Yasuda Y, Kozuka S, Matano K, Miura Y, Taniguchi T. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 1998;16:150-5.
12. Ichikawa Y, Yamagata H, Tochikubo K, Udaka S. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiol Lett 1993;111:219-24.
13. Isaka M, Yasuda Y, Kozuka S, et al. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant. Vaccine 1999;18:743-51.
14. Kurono Y, Yamamoto M, Fujihashi K, Kodama S, Suzuki M, Mogi G, McGhee JR, Kiyono H. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J Infect Dis 1999;180:122-32.
15. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995;92:6499-503.
16. Pappo J, Thomas WD Jr, Kabok Z, Taylor NS, Murphy JC, Fox JG. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun 1995;63:1246-52.
17. Goto T, Nishizono A, Fujioka T, Ikewaki J, Mifune K, Nasu M. Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice. Infect Immun 1999;67:2531-9.
18. Yasuda Y, Matano K, Asai T, Tochikubo K. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant. FEMS Immunol Med Microbiol 1998;20:311-8.
19. Watanabe K, Joh T, Seno K, Sasaki M, Todoroki I, Miyashita M, Tochikubo K, Itoh M. Development and clinical application of an immunoassay using intact Helicobacter pylori attached to a solid phase as an antigen. Clin Biochem 2001;34:291-5.
20. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.
21. Croitoru K. Helicobacter plori - Role of mucosal T cells in disease pathogenesis. Mucosal Immunology Update 1994;2:3-5.
22. Czinn SJ, Nedrud JG. Oral immunization against Helicobacter pylori. Infect Immun 1991;59:2359-63.